|
|
|
 |
|
 |
Press Releases
| |
|
| |
|
| |
Kamada Announces Equity Participation by Hercules; Concludes Financing Series
May 21, 2009
Weizmann Science Park, Ness Ziona, Israel, May 21, 2009 – Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that Hercules Technology Growth Capital, Inc. (“Hercules”) has exercised ...
Click here to read the full Press Release
| | | | | | Kamada Presents New Data on its Alpha-1 Antitrypsin at the American Thoracic Society Annual Meeting
May 20, 2009
Weizmann Science Park, Ness Ziona, Israel, May 19, 2009 – Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, today announced that new, positive clinical data on its lead candidate, alpha-1 antitrypsin (“A...
Click here to read the full Press Release
| | | | | | Kamada Raises an Additional ~US$10 Million in a Private Allocation of Common Stock
May 19, 2009
NESS ZIONA, Israel, May 19, 2009, Kamada (TASE:KMDA), a biopharmaceutical company engaged in the development, production and marketing of specialty life-saving biotherapeutics, announced today that, pursuant to agreements dated February 23 2009 and May 10 2009, it has completed the private alloca...
Click here to read the full Press Release
| | | | | | Kamada Raises an Additional ~US$ 1.5 Million in a Private Allocation of Common Stock
May 11, 2009
NESS ZIONA, Israel. May 11, 2009. Kamada (TASE:KMDA), a biopharmaceutical company engaged in the development, production and marketing of specialty life-saving biotherapeutics announced today that, pursuant to an agreement dated February 23, 2009, it has completed the private allocation of the co...
Click here to read the full Press Release
| | | | | | Kamada Announces Two Abstracts on Alpha-1 Antitrypsin Accepted for Presentation at the International Conference of the American Thoracic Society
May 4, 2009
Weizmann Science Park, Ness Ziona, Israel, May 4, 2009 – Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, today announced that two abstracts on the Company&rsq...
Click here to read the full Press Release
| | | | | | Kamada Announces Closing of approximately US$ 7 Million Private Allocation of Common Stock
May 4, 2009
NESS ZIONA, Israel. May 4, 2009. Kamada (TASE:KMDA), a biopharmaceutical company engaged in the development, production and marketing of specialty life-saving biotherapeutics announced today that, pursuant to an agreement dated February 23, 2009, it has completed the private allocation of 2...
Click here to read the full Press Release
| | | | | |
|
|
|
|
|
|
More
|
|
